MetaADEDB 2.0 @ LMMD
pirfenidone
(ISWRGOKTTBVCFA-UHFFFAOYSA-N)
Structure
SMILES
Cc1ccc(=O)n(c1)c1ccccc1
Type(s)
Approved; Investigational
ATC code(s)
L04AX05
Molecular Formula:
C12H11NO
Molecular Weight:
185.222
Log P:
2.1459
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
0
TPSA:
22
CAS Number(s):
53179-13-8
Synonym(s)
1.
pirfenidone
2.
5-methyl-1-phenyl-2-(1H)-pyridone
3.
Deskar
4.
Esbriet
External Link(s)
MeSHC093844
PubChem Compound40632
BindingDB50005201
ChEBI32016
CHEMBLCHEMBL1256391
DrugBankDB04951
DrugCentral4224
IUPHAR/BPS Guide to PHARMACOLOGY7532
KEGGdr:D01583
Therapeutic Target DatabaseD02WCI
ZINC1958
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 1784
Canada Vigilance: 23
Canada Vigilance
SIDER
US FAERS
2FatigueFAERS: 1211
Canada Vigilance: 30
Canada Vigilance
SIDER
US FAERS
3Weight decreasedFAERS: 696
Canada Vigilance: 14
Canada Vigilance
SIDER
US FAERS
4DizzinessFAERS: 673
Canada Vigilance: 11
Canada Vigilance
SIDER
US FAERS
5Abdominal discomfortFAERS: 531
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
6HeadacheFAERS: 448
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
7VomitingFAERS: 441
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
8MalaiseFAERS: 434
Canada Vigilance: 8
Canada Vigilance
US FAERS
9DyspepsiaFAERS: 395
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
10AstheniaFAERS: 370
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
11PruritusFAERS: 366
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
12PneumoniaFAERS: 358
Canada Vigilance: 13
Canada Vigilance
US FAERS
13Drug ineffectiveFAERS: 246
Canada Vigilance: 3
Canada Vigilance
US FAERS
14ConstipationFAERS: 204
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
15No adverse eventFAERS: 195US FAERS
16DysgeusiaFAERS: 169SIDER
US FAERS
17SunburnFAERS: 149
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
18Drug dose omissionFAERS: 136US FAERS
19NasopharyngitisFAERS: 131
Canada Vigilance: 6
Canada Vigilance
US FAERS
20PainFAERS: 125
Canada Vigilance: 6
Canada Vigilance
US FAERS
21Abdominal PainFAERS: 120
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
22ErythemaFAERS: 119
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
23SomnolenceFAERS: 119
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
24Productive CoughFAERS: 117
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
25ArthralgiaFAERS: 109
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
26Chest PainFAERS: 103
Canada Vigilance: 4
Canada Vigilance
US FAERS
27Feeling abnormalFAERS: 102
Canada Vigilance: 1
Canada Vigilance
US FAERS
28General physical health deteriorationFAERS: 97
Canada Vigilance: 1
Canada Vigilance
US FAERS
29Intentional product use issueFAERS: 82US FAERS
30Idiopathic Pulmonary FibrosisFAERS: 81
Canada Vigilance: 3
30481203CTD
Canada Vigilance
US FAERS
31Urinary tract infectionFAERS: 80
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
32Respiratory FailureFAERS: 79
Canada Vigilance: 2
Canada Vigilance
US FAERS
33InfectionFAERS: 77SIDER
US FAERS
34Lower respiratory tract infectionFAERS: 77
Canada Vigilance: 2
Canada Vigilance
US FAERS
35Back PainFAERS: 75
Canada Vigilance: 3
Canada Vigilance
US FAERS
36Peripheral swellingFAERS: 73
Canada Vigilance: 2
Canada Vigilance
US FAERS
37UrticariaFAERS: 72US FAERS
38FlatulenceFAERS: 71
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
39AgeusiaFAERS: 69
Canada Vigilance: 1
Canada Vigilance
US FAERS
40LethargyFAERS: 66
Canada Vigilance: 1
Canada Vigilance
US FAERS
41Dry skinFAERS: 63SIDER
US FAERS
42BronchitisFAERS: 61US FAERS
43Myocardial InfarctionFAERS: 61
Canada Vigilance: 4
Canada Vigilance
US FAERS
44AnxietyFAERS: 60
Canada Vigilance: 5
Canada Vigilance
US FAERS
45SinusitisFAERS: 60US FAERS
46HypersensitivityFAERS: 59
Canada Vigilance: 4
Canada Vigilance
US FAERS
47Cerebrovascular accidentFAERS: 56
Canada Vigilance: 4
Canada Vigilance
US FAERS
48MyalgiaFAERS: 55
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
49InfluenzaFAERS: 52
Canada Vigilance: 3
Canada Vigilance
US FAERS
50TremorFAERS: 51
Canada Vigilance: 3
Canada Vigilance
US FAERS
51HypotensionFAERS: 50US FAERS
52Memory impairmentFAERS: 49
Canada Vigilance: 2
Canada Vigilance
US FAERS
53AlopeciaFAERS: 48US FAERS
54PneumothoraxFAERS: 46
Canada Vigilance: 3
Canada Vigilance
US FAERS
55Rash erythematousFAERS: 45
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
56DehydrationFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
57Disease ProgressionFAERS: 39US FAERS
58VertigoFAERS: 39US FAERS
59Cardiac ArrestFAERS: 38US FAERS
60Pulmonary EmbolismFAERS: 37US FAERS
61ChillsFAERS: 36US FAERS
62EpistaxisFAERS: 36US FAERS
63Pulmonary function test decreasedFAERS: 36
Canada Vigilance: 11
Canada Vigilance
US FAERS
64Atrial FibrillationFAERS: 35US FAERS
65Chest discomfortFAERS: 35US FAERS
66Pulmonary FibrosisFAERS: 35
Canada Vigilance: 1

View details

CTD
Canada Vigilance
US FAERS
67Throat irritationFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
68ChromaturiaFAERS: 32US FAERS
69EructationFAERS: 31US FAERS
70Pulmonary HypertensionFAERS: 31US FAERS
71Burning sensationFAERS: 30US FAERS
72HypophagiaFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
73Skin reactionFAERS: 30US FAERS
74SwellingFAERS: 30
Canada Vigilance: 3
Canada Vigilance
US FAERS
75SyncopeFAERS: 28
Canada Vigilance: 4
Canada Vigilance
US FAERS
76AmnesiaFAERS: 27
Canada Vigilance: 4
Canada Vigilance
US FAERS
77SepsisFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
78ThrombosisFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
79Oropharyngeal painFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
80DysphoniaFAERS: 25US FAERS
81SneezingFAERS: 25US FAERS
82Depressed moodFAERS: 24US FAERS
83HepatotoxicityFAERS: 24US FAERS
84HypoxiaFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
85PalpitationsFAERS: 24US FAERS
86Therapy cessationFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
87Acute respiratory failureFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
88Medication ErrorFAERS: 22US FAERS
89Skin irritationFAERS: 22US FAERS
90Visual ImpairmentFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
91DiscomfortFAERS: 21US FAERS
92Joint swellingFAERS: 21US FAERS
93Musculoskeletal PainFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
94HypersomniaFAERS: 20US FAERS
95Product dose omissionFAERS: 20US FAERS
96Blood glucose increasedFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
97EczemaFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
98Musculoskeletal stiffnessFAERS: 19US FAERS
99ArthritisFAERS: 18US FAERS
100Incorrect dose administeredFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
101Skin UlcerFAERS: 18US FAERS
102FlushingFAERS: 17US FAERS
103PancreatitisFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
104RetchingFAERS: 17US FAERS
105GastritisFAERS: 16
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
106NervousnessFAERS: 16US FAERS
107Pulmonary arterial hypertensionFAERS: 16US FAERS
108Secretion dischargeFAERS: 16US FAERS
109Blood urine presentFAERS: 15US FAERS
110DiverticulitisFAERS: 15US FAERS
111Intercepted medication errorFAERS: 15US FAERS
112Blood alkaline phosphatase increasedFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
113Blood cholesterol increasedFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
114HerniaFAERS: 14US FAERS
115InflammationFAERS: 14
Canada Vigilance: 1
24161914CTD
Canada Vigilance
US FAERS
116AnosmiaFAERS: 13US FAERS
117CystitisFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
118Mood swingsFAERS: 13US FAERS
119OverdoseFAERS: 13US FAERS
120Food aversionFAERS: 12US FAERS
121Gastric infectionFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
122Pulmonary thrombosisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
123Angina PectorisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
124CataractFAERS: 11US FAERS
125ChokingFAERS: 11US FAERS
126CholelithiasisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
127DisorientationFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
128Intestinal ObstructionFAERS: 11US FAERS
129PhotophobiaFAERS: 11US FAERS
130Poor quality sleepFAERS: 11US FAERS
131StressFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
132Therapy non-responderFAERS: 11US FAERS
133TinnitusFAERS: 11US FAERS
134Acute myocardial infarctionFAERS: 10US FAERS
135Bone painFAERS: 10US FAERS
136Circumstance or information capable of leading to medication errorFAERS: 10US FAERS
137DermatitisFAERS: 10SIDER
US FAERS
138Diabetes MellitusFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
139DysuriaFAERS: 10US FAERS
140Middle insomniaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
141Night sweatsFAERS: 10US FAERS
142AngioedemaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
143ArthropathyFAERS: 9
Canada Vigilance: 3
Canada Vigilance
US FAERS
144AsthmaFAERS: 9US FAERS
145Blood sodium decreasedFAERS: 9US FAERS
146ColitisFAERS: 9US FAERS
147DeafnessFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
148Feeling ColdFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
149Feeling jitteryFAERS: 9US FAERS
150Gastrointestinal PainFAERS: 9SIDER
US FAERS
151Mental impairmentFAERS: 9US FAERS
152Muscle strainFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
153Oxygen consumption increasedFAERS: 9US FAERS
154Product quality issueFAERS: 9US FAERS
155Respiratory distressFAERS: 9US FAERS
156Restless Legs SyndromeFAERS: 9US FAERS
157SluggishnessFAERS: 9US FAERS
158Upper-airway cough syndromeFAERS: 9US FAERS
159AbasiaFAERS: 8US FAERS
160AcneFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
161AngerFAERS: 8US FAERS
162Aspartate Aminotransferase IncreasedFAERS: 8SIDER
US FAERS
163Back disorderFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
164Extra dose administeredFAERS: 8US FAERS
165Eye painFAERS: 8US FAERS
166Gastric ulcerFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
167HyperchlorhydriaFAERS: 8US FAERS
168Inappropriate schedule of drug administrationFAERS: 8US FAERS
169LeukopeniaFAERS: 8US FAERS
170Musculoskeletal chest painFAERS: 8US FAERS
171Neck PainFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
172NephrolithiasisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
173Oral painFAERS: 8US FAERS
174Rheumatoid ArthritisFAERS: 8US FAERS
175Skin lesionFAERS: 8
Canada Vigilance: 4
Canada Vigilance
US FAERS
176UlcerFAERS: 8US FAERS
177Unevaluable eventFAERS: 8US FAERS
178WheezingFAERS: 8US FAERS
179Alanine Aminotransferase IncreasedFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
180CellulitisFAERS: 7US FAERS
181Chronic respiratory failureFAERS: 7US FAERS
182Cold sweatFAERS: 7US FAERS
183GastroenteritisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
184GoutFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
185Head discomfortFAERS: 7US FAERS
186HypogeusiaFAERS: 7US FAERS
187Initial insomniaFAERS: 7US FAERS
188Intentional product misuseFAERS: 7US FAERS
189Joint stiffnessFAERS: 7US FAERS
190Limb discomfortFAERS: 7US FAERS
191Lip swellingFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
192Loss of personal independence in daily activitiesFAERS: 7US FAERS
193Quality of life decreasedFAERS: 7US FAERS
194TachycardiaFAERS: 7US FAERS
195Viral upper respiratory tract infectionFAERS: 7US FAERS
196AphoniaFAERS: 6US FAERS
197BedriddenFAERS: 6US FAERS
198CatarrhFAERS: 6US FAERS
199CryingFAERS: 6US FAERS
200DementiaFAERS: 6US FAERS
201Electrolyte imbalanceFAERS: 6US FAERS
202FibrosisFAERS: 624161914CTD
US FAERS
203Gamma-Glutamyltransferase IncreasedFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
204HepatitisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
205HungerFAERS: 6US FAERS
206Intercepted product storage errorFAERS: 6US FAERS
207LacerationFAERS: 6US FAERS
208NeutropeniaFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
209NoduleFAERS: 6US FAERS
210PneumonitisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
211Product storage errorFAERS: 6US FAERS
212Right ventricular failureFAERS: 6US FAERS
213Septic ShockFAERS: 6US FAERS
214Sinus operationFAERS: 6US FAERS
215Terminal stateFAERS: 6US FAERS
216Acute kidney injuryFAERS: 5US FAERS
217Allergy to chemicalsFAERS: 5US FAERS
218ApathyFAERS: 5US FAERS
219Blood glucose decreasedFAERS: 5US FAERS
220Blood iron decreasedFAERS: 5US FAERS
221Cerebral InfarctionFAERS: 5US FAERS
222Deep Vein ThrombosisFAERS: 5US FAERS
223Drug administration errorFAERS: 5US FAERS
224EosinophiliaFAERS: 5US FAERS
225Epigastric discomfortFAERS: 5US FAERS
226Eye irritationFAERS: 5US FAERS
227Fluid overloadFAERS: 5US FAERS
228Food PoisoningFAERS: 5US FAERS
229Gait inabilityFAERS: 5US FAERS
230Increased tendency to bruiseFAERS: 5US FAERS
231Irritable Bowel SyndromeFAERS: 5US FAERS
232LazinessFAERS: 5US FAERS
233Lower respiratory tract congestionFAERS: 5US FAERS
234Macular degenerationFAERS: 5US FAERS
235Mental status changesFAERS: 5US FAERS
236Paranasal sinus hypersecretionFAERS: 5US FAERS
237Product use complaintFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
238Respiratory arrestFAERS: 5US FAERS
239Therapy changeFAERS: 5US FAERS
240White blood cell count decreasedFAERS: 5US FAERS
241jaundiceFAERS: 5US FAERS
242nervous system disorderFAERS: 5SIDER
US FAERS
243skin abrasionFAERS: 5US FAERS
244Acute Coronary SyndromeFAERS: 4US FAERS
245AgitationFAERS: 4US FAERS
246Arthropod biteFAERS: 4US FAERS
247Basal cell carcinomaFAERS: 4US FAERS
248BlindnessFAERS: 4US FAERS
249Blister ruptureFAERS: 4US FAERS
250Blood folate decreasedFAERS: 4US FAERS
251Blood magnesium decreasedFAERS: 4US FAERS
252Blood potassium decreasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
253Blood pressure fluctuationFAERS: 4US FAERS
254Carbon dioxide increasedFAERS: 4US FAERS
255CardiomegalyFAERS: 4US FAERS
256CheilitisFAERS: 4US FAERS
257CholecystitisFAERS: 4US FAERS
258Clostridium difficile infectionFAERS: 4US FAERS
259DiplopiaFAERS: 4US FAERS
260DiverticulumFAERS: 4US FAERS
261Emotional disorderFAERS: 4US FAERS
262Erectile dysfunctionFAERS: 4US FAERS
263FractureFAERS: 4US FAERS
264Frustration tolerance decreasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
265Gastrointestinal infectionFAERS: 4US FAERS
266Heavy exposure to ultraviolet lightFAERS: 4US FAERS
267Incorrect product storageFAERS: 4US FAERS
268Increased upper airway secretionFAERS: 4US FAERS
269LeukocytosisFAERS: 4US FAERS
270Limb injuryFAERS: 4US FAERS
271LymphopeniaFAERS: 4US FAERS
272Oxygen saturation abnormalFAERS: 4US FAERS
273PleurisyFAERS: 4US FAERS
274Product administration errorFAERS: 4US FAERS
275Respiratory tract infection viralFAERS: 4US FAERS
276RestlessnessFAERS: 4US FAERS
277SciaticaFAERS: 4US FAERS
278StomatitisFAERS: 4US FAERS
279Thermal burnFAERS: 4US FAERS
280ThrombocytopeniaFAERS: 4US FAERS
281Toxicity to various agentsFAERS: 4US FAERS
282Upper respiratory tract congestionFAERS: 4US FAERS
283Wrong technique in product usage processFAERS: 4US FAERS
284Accidental overdoseFAERS: 3US FAERS
285Aortic AneurysmFAERS: 3US FAERS
286AphasiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
287Arthropod stingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
288Bacterial disease carrierFAERS: 3US FAERS
289Blood bilirubin decreasedFAERS: 3US FAERS
290Blood creatinine increasedFAERS: 3US FAERS
291Blood glucose fluctuationFAERS: 3US FAERS
292BronchiectasisFAERS: 3US FAERS
293Cardiac FlutterFAERS: 3US FAERS
294Cardiac ablationFAERS: 3US FAERS
295Cardiac discomfortFAERS: 3US FAERS
296Coronary Artery DiseaseFAERS: 3US FAERS
297Dermatitis acneiformFAERS: 3US FAERS
298Device related infectionFAERS: 3US FAERS
299Diabetic ulcerFAERS: 3US FAERS
300Gastroenteritis norovirusFAERS: 3US FAERS
301Gastrointestinal viral infectionFAERS: 3US FAERS
302HypothyroidismFAERS: 3US FAERS
303Increased viscosity of bronchial secretionFAERS: 3US FAERS
304InfarctionFAERS: 3US FAERS
305LaryngitisFAERS: 3US FAERS
306LymphadenopathyFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
307Mastication disorderFAERS: 3US FAERS
308Muscle FatigueFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
309Myocardial strainFAERS: 3US FAERS
310NeuralgiaFAERS: 3US FAERS
311Ocular icterusFAERS: 3US FAERS
312Oral dischargeFAERS: 3US FAERS
313Oropharyngeal discomfortFAERS: 3US FAERS
314Pain of skinFAERS: 3US FAERS
315Pancreatic carcinomaFAERS: 3US FAERS
316Performance status decreasedFAERS: 3US FAERS
317Personality ChangeFAERS: 3US FAERS
318PhlebitisFAERS: 3US FAERS
319Post-tussive vomitingFAERS: 3US FAERS
320PresyncopeFAERS: 3US FAERS
321Product container issueFAERS: 3US FAERS
322Product taste abnormalFAERS: 3US FAERS
323Product use in unapproved indicationFAERS: 3US FAERS
324PsoriasisFAERS: 3US FAERS
325Pulmonary painFAERS: 3US FAERS
326RegurgitationFAERS: 3US FAERS
327SarcoidosisFAERS: 3US FAERS
328ScabFAERS: 3US FAERS
329Solar dermatitisFAERS: 3US FAERS
330Spinal column stenosisFAERS: 3US FAERS
331Throat cancerFAERS: 3US FAERS
332Tongue blisteringFAERS: 3US FAERS
333TuberculosisFAERS: 3US FAERS
334Urinary IncontinenceFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
335Urinary RetentionFAERS: 3US FAERS
336VasculitisFAERS: 3US FAERS
337Wound InfectionFAERS: 3US FAERS
338Abdominal rigidityFAERS: 2US FAERS
339Abdominal tendernessFAERS: 2US FAERS
340Anal FistulaFAERS: 2US FAERS
341Anaphylactic shockFAERS: 2US FAERS
342AneurysmFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
343Angular cheilitisFAERS: 2US FAERS
344Ankle FractureFAERS: 2US FAERS
345AscitesFAERS: 2US FAERS
346Aspartate aminotransferase abnormalFAERS: 2US FAERS
347Atrial FlutterFAERS: 2US FAERS
348Atrioventricular BlockFAERS: 2US FAERS
349Autonomic nervous system imbalanceFAERS: 2US FAERS
350Bacterial sepsisFAERS: 2US FAERS
351Benign NeoplasmFAERS: 2US FAERS
352Benign Prostatic HyperplasiaFAERS: 2US FAERS
353Bladder NeoplasmFAERS: 2US FAERS
354Blood count abnormalFAERS: 2US FAERS
355Blood creatine phosphokinase increasedFAERS: 2US FAERS
356Blood glucose abnormalFAERS: 2US FAERS
357Blood lactate dehydrogenase increasedFAERS: 2US FAERS
358Blood potassium increasedFAERS: 2US FAERS
359Bowel movement irregularityFAERS: 2US FAERS
360BradycardiaFAERS: 2US FAERS
361Cerebral disorderFAERS: 2US FAERS
362Choking sensationFAERS: 2US FAERS
363Cholecystitis infectiveFAERS: 2US FAERS
364Completed SuicideFAERS: 2US FAERS
365ConjunctivitisFAERS: 2US FAERS
366Creatinine renal clearance increasedFAERS: 2US FAERS
367CyanosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
368DeliriumFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
369Depressed Level of ConsciousnessFAERS: 2US FAERS
370Diabetes mellitus inadequate controlFAERS: 2US FAERS
371Disease complicationFAERS: 2US FAERS
372DysarthriaFAERS: 2US FAERS
373DysenteryFAERS: 2US FAERS
374Early satietyFAERS: 2US FAERS
375EcchymosisFAERS: 2US FAERS
376Economic problemFAERS: 2US FAERS
377EctropionFAERS: 2US FAERS
378Ejection Fraction DecreasedFAERS: 2US FAERS
379Electrocardiogram abnormalFAERS: 2US FAERS
380Emotional distressFAERS: 2US FAERS
381Erythema MultiformeFAERS: 2US FAERS
382Facial PainFAERS: 2US FAERS
383Failure to ThriveFAERS: 2US FAERS
384FasciitisFAERS: 2US FAERS
385FibromyalgiaFAERS: 2US FAERS
386Flank PainFAERS: 2US FAERS
387FormicationFAERS: 2US FAERS
388Gastric DilatationFAERS: 2US FAERS
389Gastrointestinal sounds abnormalFAERS: 2US FAERS
390Gastrointestinal toxicityFAERS: 2US FAERS
391GranulomaFAERS: 2US FAERS
392Guillain-Barre SyndromeFAERS: 2US FAERS
393HemiparesisFAERS: 2US FAERS
394Hepatopulmonary SyndromeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
395HordeolumFAERS: 2US FAERS
396HyperkeratosisFAERS: 2US FAERS
397HyperphagiaFAERS: 2US FAERS
398HypokinesiaFAERS: 2US FAERS
399HypoventilationFAERS: 2US FAERS
400ImmobileFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
401IncontinenceFAERS: 2US FAERS
402Incorrect route of drug administrationFAERS: 2US FAERS
403Infectious colitisFAERS: 2US FAERS
404Infrequent bowel movementsFAERS: 2US FAERS
405Insurance issueFAERS: 2US FAERS
406Lactose IntoleranceFAERS: 2US FAERS
407Limb massFAERS: 2US FAERS
408Liver function test decreasedFAERS: 2US FAERS
409Lung AbscessFAERS: 2US FAERS
410MYELODYSPLASTIC SYNDROMEFAERS: 2US FAERS
411MaculeFAERS: 2US FAERS
412Malignant neoplasm progressionFAERS: 2US FAERS
413MalnutritionFAERS: 2SIDER
US FAERS
414Metastatic NeoplasmFAERS: 2US FAERS
415Nasal inflammationFAERS: 2US FAERS
416Nasal pruritusFAERS: 2US FAERS
417Negative thoughtsFAERS: 2US FAERS
418Ocular cancer metastaticFAERS: 2US FAERS
419Oral mucosal eruptionFAERS: 2US FAERS
420Orchitis noninfectiveFAERS: 2US FAERS
421OsteomyelitisFAERS: 2US FAERS
422PallorFAERS: 2US FAERS
423PancytopeniaFAERS: 2US FAERS
424Parkinsonian rest tremorFAERS: 2US FAERS
425PharyngitisFAERS: 2US FAERS
426Physical deconditioningFAERS: 2US FAERS
427Product dispensing errorFAERS: 2US FAERS
428Product physical issueFAERS: 2US FAERS
429Product solubility abnormalFAERS: 2US FAERS
430Protein urine presentFAERS: 2US FAERS
431Pulmonary congestionFAERS: 2US FAERS
432RalesFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
433Renal ColicFAERS: 2US FAERS
434Renal cystFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
435Renal painFAERS: 2US FAERS
436Respiratory tract congestionFAERS: 2US FAERS
437Retinal DetachmentFAERS: 2US FAERS
438Retinal Vein OcclusionFAERS: 2US FAERS
439RhinitisFAERS: 2US FAERS
440RosaceaFAERS: 2US FAERS
441Rotator cuff syndromeFAERS: 2US FAERS
442Skin WrinklingFAERS: 2US FAERS
443Skin hypertrophyFAERS: 2US FAERS
444Sputum retentionFAERS: 2US FAERS
445Squamous cell carcinoma of skinFAERS: 2US FAERS
446Squamous cell carcinomaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
447StrabismusFAERS: 2US FAERS
448Sudden deathFAERS: 2US FAERS
449Suspected counterfeit productFAERS: 2US FAERS
450ThirstFAERS: 2US FAERS
451Thrombocytopenic purpuraFAERS: 2US FAERS
452Tongue erythemaFAERS: 2US FAERS
453Tooth ExtractionFAERS: 2US FAERS
454Tooth InfectionFAERS: 2US FAERS
455Tooth LossFAERS: 2US FAERS
456TrichorrhexisFAERS: 2US FAERS
457Urinary hesitationFAERS: 2US FAERS
458Urine flow decreasedFAERS: 2US FAERS
459Vaginal DischargeFAERS: 2US FAERS
460Vocal Cord ParalysisFAERS: 2US FAERS
461treatment failureFAERS: 2US FAERS
462Abdominal InfectionFAERS: 1US FAERS
463Accidental exposure to productFAERS: 1US FAERS
464Accidental exposure to product by childFAERS: 1US FAERS
465AcidosisFAERS: 1US FAERS
466Actinic keratosisFAERS: 1US FAERS
467Activities of daily living impairedFAERS: 1US FAERS
468Acute psychosisFAERS: 1US FAERS
469Acute sinusitisFAERS: 1US FAERS
470AdenocarcinomaFAERS: 1US FAERS
471Amylase abnormalFAERS: 1US FAERS
472Amylase increasedFAERS: 1US FAERS
473Anal fistula infectionFAERS: 1US FAERS
474AngioplastyFAERS: 1US FAERS
475Antibody test positiveFAERS: 1US FAERS
476Anticoagulation drug level below therapeuticFAERS: 1US FAERS
477AppendicitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
478Arterial thrombosisFAERS: 1US FAERS
479AsbestosisFAERS: 1US FAERS
480AsphyxiaFAERS: 1US FAERS
481AsthenopiaFAERS: 1US FAERS
482Bilevel positive airway pressureFAERS: 1US FAERS
483Biliary tract infectionFAERS: 1US FAERS
484Blood bilirubin abnormalFAERS: 1US FAERS
485Blood creatinine decreasedFAERS: 1US FAERS
486Blood electrolytes decreasedFAERS: 1US FAERS
487Blood gases abnormalFAERS: 1US FAERS
488Blood immunoglobulin G increasedFAERS: 1US FAERS
489Blood iron increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
490Blood pH increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
491Blood urea increasedFAERS: 1US FAERS
492Blood viscosity abnormalFAERS: 1US FAERS
493Breast cancer stage IIFAERS: 1US FAERS
494BronchiolitisFAERS: 1US FAERS
495BronchospasmFAERS: 1US FAERS
496BruxismFAERS: 1US FAERS
497CD4 Lymphocytes DecreasedFAERS: 1US FAERS
498CachexiaFAERS: 1US FAERS
499Campylobacter infectionFAERS: 1US FAERS
500Carbon dioxide decreasedFAERS: 1US FAERS
501Cardiac TamponadeFAERS: 1US FAERS
502Cardiac infectionFAERS: 1US FAERS
503Cardiac ventricular disorderFAERS: 1US FAERS
504Cataract operationFAERS: 1US FAERS
505Cerebellar infarctionFAERS: 1US FAERS
506CholangitisFAERS: 1US FAERS
507CholestasisFAERS: 1US FAERS
508Chronic Actinic DermatitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
509ClaustrophobiaFAERS: 1US FAERS
510Clostridium difficile colitisFAERS: 1US FAERS
511Compression fractureFAERS: 1US FAERS
512Coronary artery insufficiencyFAERS: 1US FAERS
513Creutzfeldt-Jakob diseaseFAERS: 1US FAERS
514Critical IllnessFAERS: 1US FAERS
515Cystic FibrosisFAERS: 1US FAERS
516CystFAERS: 1US FAERS
517Device FailureFAERS: 1US FAERS
518Diabetic RetinopathyFAERS: 1US FAERS
519Diffuse Large B-Cell LymphomaFAERS: 1US FAERS
520Diffuse alopeciaFAERS: 1US FAERS
521Diffuse alveolar damageFAERS: 1US FAERS
522DisabilityFAERS: 1US FAERS
523DissociationFAERS: 1US FAERS
524Drug prescribing errorFAERS: 1US FAERS
525DyscheziaFAERS: 1US FAERS
526DysplasiaFAERS: 1US FAERS
527Ear congestionFAERS: 1US FAERS
528Electrocardiogram changeFAERS: 1US FAERS
529EncephalitisFAERS: 1US FAERS
530EndocarditisFAERS: 1US FAERS
531Enzyme abnormalityFAERS: 1US FAERS
532Escherichia infectionFAERS: 1US FAERS
533Escherichia test positiveFAERS: 1US FAERS
534EuthanasiaFAERS: 1US FAERS
535Exfoliative rashFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
536Eyelid Function DisorderFAERS: 1US FAERS
537Eyelid margin crustingFAERS: 1US FAERS
538Febrile NeutropeniaFAERS: 1US FAERS
539Feeling of body temperature changeFAERS: 1US FAERS
540Foaming at mouthFAERS: 1US FAERS
541Food AllergyFAERS: 1US FAERS
542Food cravingFAERS: 1US FAERS
543FrostbiteFAERS: 1US FAERS
544FrustrationFAERS: 1US FAERS
545Full blood count decreasedFAERS: 1US FAERS
546Gallbladder hypofunctionFAERS: 1US FAERS
547Gastric pH decreasedFAERS: 1US FAERS
548GastrostomyFAERS: 1US FAERS
549General physical condition abnormalFAERS: 1US FAERS
550Genital burning sensationFAERS: 1US FAERS
551Genital rashFAERS: 1US FAERS
552GingivitisFAERS: 1US FAERS
553GlaucomaFAERS: 1US FAERS
554Hair injuryFAERS: 1US FAERS
555Head titubationFAERS: 1US FAERS
556HemiplegiaFAERS: 1US FAERS
557Hepatic congestionFAERS: 1US FAERS
558Hepatitis CFAERS: 1US FAERS
559Hepatitis EFAERS: 1US FAERS
560HepatomegalyFAERS: 1US FAERS
561High density lipoprotein increasedFAERS: 1US FAERS
562Hospice CareFAERS: 1US FAERS
563Hypertensive crisisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
564HyperventilationFAERS: 1US FAERS
565HypometabolismFAERS: 1US FAERS
566Hyporesponsive to stimuliFAERS: 1US FAERS
567IleusFAERS: 1US FAERS
568Immune thrombocytopenic purpuraFAERS: 1US FAERS
569ImmunosuppressionFAERS: 1US FAERS
570Impaired quality of lifeFAERS: 1US FAERS
571Inappropriate schedule of product administrationFAERS: 1US FAERS
572Incarcerated herniaFAERS: 1US FAERS
573IncoherentFAERS: 1US FAERS
574Increased bronchial secretionFAERS: 1US FAERS
575Increased viscosity of upper respiratory secretionFAERS: 1US FAERS
576Inflammatory marker increasedFAERS: 1US FAERS
577Intellectual DisabilityFAERS: 1US FAERS
578Intercepted drug prescribing errorFAERS: 1US FAERS
579Intestinal PerforationFAERS: 1US FAERS
580Intestinal scarringFAERS: 1US FAERS
581Joint Range of Motion DecreasedFAERS: 1US FAERS
582Joint injuryFAERS: 1US FAERS
583Joint laxityFAERS: 1US FAERS
584LaryngospasmFAERS: 1US FAERS
585Latent TuberculosisFAERS: 1US FAERS
586LeukoplakiaFAERS: 1US FAERS
587LichenificationFAERS: 1US FAERS
588Lipase abnormalFAERS: 1US FAERS
589Loose toothFAERS: 1US FAERS
590Lung cystFAERS: 1US FAERS
591Lung squamous cell carcinoma stage IVFAERS: 1US FAERS
592Lung transplant rejectionFAERS: 1US FAERS
593Lupus-like syndromeFAERS: 1US FAERS
594Lyme DiseaseFAERS: 1US FAERS
595LymphadenitisFAERS: 1US FAERS
596LymphomaFAERS: 1US FAERS
597Manufacturing product shipping issueFAERS: 1US FAERS
598Mechanical urticariaFAERS: 1US FAERS
599Mechanical ventilationFAERS: 1US FAERS
600Medical observationFAERS: 1US FAERS
601Meniscus injuryFAERS: 1US FAERS
602Mesenteric PanniculitisFAERS: 1US FAERS
603Metabolic acidosisFAERS: 1US FAERS
604Monoclonal immunoglobulin presentFAERS: 1US FAERS
605Monocyte count decreasedFAERS: 1US FAERS
606Mononeuropathy MultiplexFAERS: 1US FAERS
607Motion SicknessFAERS: 1US FAERS
608Musculoskeletal discomfortFAERS: 1SIDER
US FAERS
609Mycosis FungoidesFAERS: 1US FAERS
610MyopiaFAERS: 1US FAERS
611MyosclerosisFAERS: 1US FAERS
612Nasal PolypsFAERS: 1US FAERS
613Nasal discomfortFAERS: 1US FAERS
614NocturiaFAERS: 1US FAERS
615Nutritional condition abnormalFAERS: 1US FAERS
616Ocular discomfortFAERS: 1US FAERS
617OnychoclasisFAERS: 1US FAERS
618OsteoporosisFAERS: 1US FAERS
619Otitis MediaFAERS: 1US FAERS
620Oxygen supplementationFAERS: 1US FAERS
621PO2 decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
622Paranasal sinus discomfortFAERS: 1US FAERS
623Pathological fractureFAERS: 1US FAERS
624Patient IsolationFAERS: 1US FAERS
625PemphigusFAERS: 1US FAERS
626Peptic UlcerFAERS: 1US FAERS
627Pericardial effusionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
628PertussisFAERS: 1US FAERS
629PetechiaeFAERS: 1US FAERS
630PhotodermatosisFAERS: 1US FAERS
631Phrenic nerve paralysisFAERS: 1US FAERS
632Pleural sarcomaFAERS: 1US FAERS
633PneumonectomyFAERS: 1US FAERS
634Polymyalgia RheumaticaFAERS: 1US FAERS
635Portal HypertensionFAERS: 1US FAERS
636Posterior reversible encephalopathy syndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
637Potentiating drug interactionFAERS: 1US FAERS
638Pre-existing condition improvedFAERS: 1US FAERS
639Precancerous cells presentFAERS: 1US FAERS
640Product difficult to swallowFAERS: 1US FAERS
641Product dispensing issueFAERS: 1US FAERS
642Product formulation issueFAERS: 1US FAERS
643Product prescribing errorFAERS: 1US FAERS
644Product prescribing issueFAERS: 1US FAERS
645Product use issueFAERS: 1US FAERS
646Prostatic painFAERS: 1US FAERS
647Protein total decreasedFAERS: 1US FAERS
648Pulmonary Valve StenosisFAERS: 1US FAERS
649PyelonephritisFAERS: 1US FAERS
650Rectal dischargeFAERS: 1US FAERS
651Respiratory ParalysisFAERS: 1US FAERS
652RhabdomyolysisFAERS: 1US FAERS
653Rheumatoid factor increasedFAERS: 1US FAERS
654Rhinovirus infectionFAERS: 1US FAERS
655Saliva alteredFAERS: 1US FAERS
656SarcomaFAERS: 1US FAERS
657Scarlet FeverFAERS: 1US FAERS
658Sense of oppressionFAERS: 1US FAERS
659Sexual DysfunctionFAERS: 1US FAERS
660Sinus TachycardiaFAERS: 1US FAERS
661Sinus headacheFAERS: 1US FAERS
662Skin toxicityFAERS: 1US FAERS
663Small cell lung cancer metastaticFAERS: 1US FAERS
664Solar lentigoFAERS: 1US FAERS
665Squamous cell carcinoma of lungFAERS: 1US FAERS
666Staphylococcus test positiveFAERS: 1US FAERS
667Stevens-Johnson SyndromeFAERS: 1US FAERS
668Stoma obstructionFAERS: 1US FAERS
669Strangulated herniaFAERS: 1US FAERS
670StuporFAERS: 1US FAERS
671Subcutaneous EmphysemaFAERS: 1US FAERS
672Suicide attemptFAERS: 1US FAERS
673SuperinfectionFAERS: 1US FAERS
674Temperature intoleranceFAERS: 1US FAERS
675Therapeutic product ineffectiveFAERS: 1US FAERS
676ToothacheFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
677Total lung capacity abnormalFAERS: 1US FAERS
678Toxic Shock SyndromeFAERS: 1US FAERS
679Tracheal painFAERS: 1US FAERS
680Transaminases increasedFAERS: 1US FAERS
681TransplantFAERS: 1US FAERS
682Trigeminal NeuralgiaFAERS: 1US FAERS
683Umbilical herniaFAERS: 1US FAERS
684Unintentional use for unapproved indicationFAERS: 1US FAERS
685Unresponsive to stimuliFAERS: 1US FAERS
686Urinary strainingFAERS: 1US FAERS
687VIIth nerve paralysisFAERS: 1US FAERS
688Vascular stenosisFAERS: 1US FAERS
689Vascular stent occlusionFAERS: 1US FAERS
690Ventricular arrhythmiaFAERS: 1US FAERS
691Ventricular hypokinesiaFAERS: 1US FAERS
692Visual acuity reduced transientlyFAERS: 1US FAERS
693VitiligoFAERS: 1US FAERS
694Vitreous floatersFAERS: 1US FAERS
695Vocal Cord DysfunctionFAERS: 1US FAERS
696Walking distance test abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
697Wheelchair userFAERS: 1US FAERS
698furuncleFAERS: 1US FAERS
699AnorexiaSIDER
700Benign neoplasm of thyroid glandCanada Vigilance: 1Canada Vigilance
701Blood alkaline phosphatase decreasedCanada Vigilance: 1Canada Vigilance
702Cardiac dysfunctionCanada Vigilance: 1Canada Vigilance
703ClubbingCanada Vigilance: 1Canada Vigilance
704EmbolismCanada Vigilance: 1Canada Vigilance
705Glomerulonephritis15561744CTD
706Heart Diseases14564477CTD
707Infected fistulaCanada Vigilance: 1Canada Vigilance
708InfestationSIDER
709Kidney Diseases14564477CTD
710Kidney Failure, Chronic20006961CTD
711Liver Cirrhosis, Experimental12445421
15571005
CTD
712Non-cardiac chest painSIDER
713Procedural complicationCanada Vigilance: 1Canada Vigilance
714Procedural nauseaCanada Vigilance: 1Canada Vigilance
715Proteinuria15561744CTD
716PrurigoSIDER
717Pulmonary Edema29273418CTD
718Restrictive pulmonary diseaseCanada Vigilance: 1Canada Vigilance
719Serum bilirubin increasedSIDER
720Transferrin saturation increasedCanada Vigilance: 1Canada Vigilance
721Upset stomachSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.